Memphis Pharmaceuticals

مادة اعلانية

Latest Update: 3 Apr 2025 16:25 Abu Dhabi Time.

Market Status: Closed

MPCI

Memphis Pharmaceuticals

78.50

EGP

-2.270

-2.81%

Open

80.77

Prev Close

80.77

PX_VOLUME

63,103

MARKET CAP (M)

DAY RANGE

77.11 - 81.45

52 WEEKS

23.93 - 84.98

Stock Statistics

Yearly Change

157.10%

Listed Shares (Million)

22.75

Earnings Multiple

3.53

Average 30-day trading volume

133,740.00

Price-to-book ratio

3.48

Earnings Per Share

11.29

Previous Dividend Distribution

3.80

Dividend Yield

5.10%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		388.26	399.66	207.33	234.79	247.14	182.65
Gross Profit		189.82	187.25	70.43	75.84	100.90	53.12
Operating Income		136.20	149.06	51.45	45.44	64.59	26.64
Profit Margin		32.77	35.24	12.10	35.56	23.52	13.56

	Period Ending:	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		871.91	663.83	551.26	518.11
Gross Profit		300.29	212.95	149.39	164.98
Operating Income		188.12	98.85	71.04	36.24
Profit Margin		21.96	13.62	13.44	8.07

Balance Sheet

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,343.04	1,330.93	1,217.04	1,127.34	1,004.16	795.79
Total Liabilities		960.80	1,042.41	1,067.96	1,059.62	856.04	667.63
Total Equity		382.23	288.51	149.08	67.73	148.12	128.16

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

MPCI

Memphis Pharmaceuticals